LEADER 02970nam a2200529 a 4500
001 036a84dc-a8bd-46ee-a187-25aae4371912
005 20230619000000.0
008 910514s1990 fr a b 101 0 eng d
020 |a 9283212509 
035 |9 FPC8693YL 
035 |a (NIC)notisAKX5670 
035 |a (OCoLC)25871399 
035 |a (OCoLC)ocn689716716 
035 |a 2134691 
035 |a 4827824 
040 |a CSt-L  |c CSt-L  |d NjR  |d NIC  |d CtY-EP 
040 |a CSt-L  |c CSt-L  |d NjR  |d NIC 
050 4 |a RC268.6  |b .I13 v.50 
079 |a ocm25871399 
245 0 0 |a Pharmaceutical drugs 
260 |a Lyon, France :  |b International Agency for Research on Cancer,  |c 1990 
300 |a 415 p. :  |b ill. ;  |c 24 cm 
440 0 |a IARC monographs on the evaluation of carcinogenic risks to humans  |x 0250-9555 ;  |v v. 50 
490 1 |a IARC monographs on the evaluation of carcinogenic risks to humans  |x 0250-9555 ;  |v v. 50 
500 |a At head of title: World Health Organization, International Agency for Research on Cancer 
500 |a This WorldCat-derived record is shareable under Open Data Commons ODC-BY, with attribution to OCLC  |5 CTY 
500 |a "This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 17-24 Oct. 1989." 
504 |a Includes bibliographical references and cumulative index 
650 0 |a Carcinogens  |v Congresses 
650 0 |a Carcinogens  |x Congresses 
650 0 |a Chemicals  |x Physiological effect  |v Congresses 
650 0 |a Chemicals  |x Physiological effect  |x Congresses 
650 0 |a Drugs  |x Physiological effect  |v Congresses 
650 0 |a Drugs  |x Physiological effect  |x Congresses 
650 7 |a Carcinogens  |2 fast 
650 7 |a Chemicals  |x Physiological effect  |2 fast 
650 7 |a Drugs  |x Physiological effect  |2 fast 
655 7 |a Conference papers and proceedings  |2 fast 
710 2 |a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans 
710 2 |a International Agency for Research on Cancer 
710 2 |a World Health Organization 
711 2 |a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans  |d (1989 :  |c Lyon, France) 
830 0 |a IARC monographs on the evaluation of carcinogenic risks to humans  |x 0250-9555 ;  |v v. 50 
999 1 0 |i 036a84dc-a8bd-46ee-a187-25aae4371912  |l 4827824  |s US-CTY  |m pharmaceutical_drugs_______________________________________________________1990_______intera___________________________________________________________________________p 
999 1 0 |i 036a84dc-a8bd-46ee-a187-25aae4371912  |l 2134691  |s US-NIC  |m pharmaceutical_drugs_______________________________________________________1990_______intera___________________________________________________________________________p 
999 1 1 |l 4827824  |s ISIL:US-CTY  |t BKS  |a med  |c RC268.57 I57 v.50  |p UNLOANABLE 
999 1 1 |l 2134691  |s ISIL:US-NIC  |t BKS  |a mann,anx  |b 31924062804624  |c RC268.6 .I13 v.50  |d lc  |k 1  |x Book  |y 3b573551-aa8c-40e2-b9f4-05c3042a4f11  |p LOANABLE